SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001140361-24-019150
Filing Date
2024-04-10
Accepted
2024-04-10 17:29:23
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-04-10

Document Format Files

Seq Description Document Type Size
1 ARS ny20018910x4_ars.pdf ARS 2140639
  Complete submission text file 0001140361-24-019150.txt   2949378
Mailing Address 611 GATEWAY BOULEVARD, SUITE 900 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BOULEVARD, SUITE 900 SOUTH SAN FRANCISCO CA 94080 650-624-1100
RIGEL PHARMACEUTICALS INC (Filer) CIK: 0001034842 (see all company filings)

IRS No.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 000-29889 | Film No.: 24836718
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)